CLINICAL_TRIALS
trial_result
· 2011-08-29
Clinical Trial Update: Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes. [Phase 2]
Summary
A Phase 2 safety and efficacy study evaluating alogliptin for glycemic control in adults with Type 2 diabetes has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2011-08-29